RETN and Insulin resistance: Its serum level is increased in cardiovascular disease (Karbowska et al. 2009; Reilly et al. 2005), other inflammation-related diseases (Pang and Lee 2006) and in diabetes (Rajala et al. 2004), however, studies relating human resistin to insulin resistance, or diabetes have shown conflicting results.